Thomas Aurigemma v. HHS - Influenza, Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) (2020)

Thomas Aurigemma filed a petition under the National Vaccine Injury Compensation Program alleging that he developed Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) as a result of receiving influenza and Hepatitis B vaccinations on October 4, 2014. The respondent, the Secretary of Health and Human Services, denied that the vaccines caused Mr.

Aurigemma's conditions. Despite maintaining their respective positions, both parties entered into a joint stipulation to settle the case and award compensation.

The stipulation was approved by the Special Master. The award includes a lump sum of $1,831,734.51 to cover first-year life care expenses, lost earnings, pain and suffering, and past unreimbursable expenses.

The remainder of the damages will be paid through an annuity contract. The Special Master adopted the stipulation as her decision and ordered that judgment be entered.